BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18174673)

  • 1. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
    Hirakata M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myositis-specific autoantibodies and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral aspects of polymyositis/dermatomyositis.
    Hirakata M
    Mod Rheumatol; 2000 Dec; 10(4):199-206. PubMed ID: 24383629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.
    Gunawardena H; Betteridge ZE; McHugh NJ
    Rheumatology (Oxford); 2009 Jun; 48(6):607-12. PubMed ID: 19439503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis].
    Sato S
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):85-93. PubMed ID: 16651706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity in polymyositis/dermatomyositis.
    Targoff IN
    J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune manifestations of inflammatory muscle disease.
    Targoff IN
    Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New autoantibodies in dermatomyositis].
    Bielsa I
    Actas Dermosifiliogr; 2009 Apr; 100(3):182-9. PubMed ID: 19457303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
    Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
    BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in polymyositis and dermatomyositis.
    Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
    Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
    Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
    Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].
    Xie MM; Yan X; Li H; Ding JJ; Gui XH; Liu Y; Wang YS; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug; 41(8):616-621. PubMed ID: 30138971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.